Article Versions Notes

Ohya Y, Ogiso Y, Matsuda M, Sakae H, Nishida K, Miki Y, Fox TE, Kester M, Sakamoto W, Nabe T, et al. Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells. 2024; 13(5):405. https://doi.org/10.3390/cells13050405

Ohya, Yuki, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E. Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, and et al. 2024. "Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells" Cells 13, no. 5: 405. https://doi.org/10.3390/cells13050405

Ohya, Y., Ogiso, Y., Matsuda, M., Sakae, H., Nishida, K., Miki, Y., Fox, T. E., Kester, M., Sakamoto, W., Nabe, T., & Kitatani, K. (2024). Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells, 13(5), 405. https://doi.org/10.3390/cells13050405